Patent · US Active

Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity

US9975875B2 · kind B2 · utility

4Cited by
26References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 18, 2017
Grant dateMay 22, 2018
Priority date—
Expiry dateAug 18, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a compound of formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.